The report will enhance your decision making capability in a more rapid and time sensitive manner

New York, NY -- (SBWire) -- 05/28/2019 --According to the 2007 Global Burden of Disease report from the World Health Organization (WHO), more than 1 billion people worldwide suffered from neurological disorders, including stroke, Alzheimer's disease, epilepsy, Parkinson's disease (PD), brain injuries, and glaucoma and other eye disorders. Nearly 7 million people died from these diseases. According to the report, one in six people is stricken by a neurological disorder every year, many of them becoming seriously disabled.

In the U.S., 1.5 million people suffer from a traumatic central nervous system (CNS) injury each year. This number consists primarily of young adults and the elderly, due to reasons such as accidents, falls, sports- and work-related injuries, combat and self-harm. One-third of injury-related deaths in the U.S. are caused by traumatic brain injuries, which also lead to serious physical disabilities, cognitive disorders and neurodegenerative diseases.

Report Scope
The scope of this report covers the global market for small molecule drugs, monoclonal antibodies, gene and cell therapies, and other biotechnology products that are approved or being developed for the treatment of neurological disorders.
Therapeutic indications are grouped under four categories: cerebrovascular diseases, neurodegenerative disorders, ophthalmic diseases and traumatic CNS injuries. Indication subcategories include stroke, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis, Huntington's disease, spinal muscular atrophy, epilepsy, glaucoma, age-related macular degeneration, optic neuropathies, diabetic retinopathy and traumatic brain and spinal cord injuries. The report does not cover the neuroprotective agents that are used for protecting the brain during risky neurosurgeries and other general operations.
Download Free Sample PDF copy of this report: https://www.marketexpertz.com/sample-enquiry-form/42248

Leading players of Neuroprotective Agents including:

- AB SCIENCE S.A.
- ACUCELA INC.
- AERIE PHARMACEUTICALS INC.
- ALLERGAN
- ASTRAZENECA PLC
- ATHERSYS INC.
- AVEXIS INC.
- BAYER HEALTHCARE
- BIOGEN INC.
- BRISTOL-MYERS SQUIBB CO.
- BOEHRINGER INGELHEIM
- BRAINSTORM CELL THERAPEUTICS INC.
- CELGENE CORP.
- CORESTEM INC.
- COVIS PHARMA
- DAIICHI SANKYO INC.
- Others

Helping you establish a strong foothold in the industry:

The Neuroprotective Agents report highlights set of information related to pricing and the category of customers who are more than willing to pay for certain products and services. The information on opportunities as well as product features, determine which offerings or benefits command sale and identify the communications channels used by the market leaders to create premium positioning strategies as well as attract broadest share.

Report Includes:

- 39 tables
- An overview of the global market for neuroprotective agents and their therapeutic applications
- Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Market breakdowns by indication, mechanism of action, and by region
- Discussion of various neurodegenerative disorders
- Profiles of key companies in the market, including Bayer Healthcare, Eisai Inc., Glaxosmithkline Plc, Merck Serono S.A., Novartis Ag and Teva Pharmaceutical Industries Ltd.

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

- North America
- Europe
- China
- Japan
- Southeast Asia
- India

Order Now Full Premium Report of Neuroprotective Agents and (Customized report delivered as per your specific requirement)@ https://www.marketexpertz.com/checkout-form/42248

The study further offers a comprehensive assessment of the revenue generated by the various segments across different regions for the forecast period, 2019 to 2026. To help business owners gain a thorough understanding of the current momentum the research taps hard to find data on aspects including but not limited to demand and supply, distribution channel and technology upgrades. Most importantly, evaluation of stringent rules and regulations and government initiatives shaping the progress of the Neuroprotective Agents industry offers an understanding of what is in store for the business owners in the years to come.

Here is the Questions We Answer…!

- What is the expected market size of the Neuroprotective Agents market for the forecast period 2019 - 2026? What will be the growth rate of the industry during the estimated period?
- What are the major driving forces shaping the future of the Neuroprotective Agents industry worldwide?
- Who are the major vendors in the industry and what are their strategies to reap more profits and reduce costs?
- What are the trends from the past and future that are likely to favor the progress of the Neuroprotective Agents industry worldwide?
- What are the major threats and challenges that hinder the development of the industry?
- What are the opportunities in store for the business owners operating in the market?

Continued….

In this study, the years considered to estimate the market size of Neuroprotective Agents are as follows:
- History Year: 2014-2018
- Base Year: 2018
- Estimated Year: 2019
- Forecast Year 2019 to 2025

Browse Full Report: https://www.marketexpertz.com/industry-overview/Neuroprotective Agents-market

About MarketExpertz
Planning to invest in market intelligence products or offerings on the web? Then marketexpertz has just the thing for you - reports from over 500 prominent publishers and updates on our collection daily to empower companies and individuals catch-up with the vital insights on industries operating across different geography, trends, share, size and growth rate. There's more to what we offer to our customers. With marketexpertz you have the choice to tap into the specialized services without any additional charges.

Contact Us:
John Watson
Head of Business Development
Market Expertz | Web: www.marketexpertz.com
Direct Line: +1-800-819-3052
E-mail: sales@marketexpertz.com
News: www.marketexpertz.com/market-news